Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus Farley JEJ Am Acad Nurse Pract 2008[Feb]; 20 (2): 85-92PURPOSE: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed. DATA SOURCES: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966-2006). CONCLUSIONS: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed. IMPLICATIONS FOR PRACTICE: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.|*Community-Acquired Infections/diagnosis/epidemiology/therapy[MESH]|*Methicillin Resistance[MESH]|*Soft Tissue Infections/diagnosis/epidemiology/therapy[MESH]|*Staphylococcal Skin Infections/diagnosis/epidemiology/therapy[MESH]|*Staphylococcus aureus[MESH]|Communicable Diseases, Emerging/diagnosis/epidemiology/therapy[MESH]|Cross Infection/diagnosis/epidemiology/therapy[MESH]|Humans[MESH]|Microbial Sensitivity Tests[MESH]|Molecular Epidemiology[MESH]|Nurse Practitioners/*organization & administration[MESH]|Nurse's Role[MESH]|Nursing Assessment[MESH]|Risk Factors[MESH] |
